The Paradise uRDN system is a novel ultrasound-based renal denervation technology designed to lower blood pressure by denervating the sympathetic nerves surrounding the renal arteries, reducing the ...
Palo Alto, CA, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Recor Medical, Inc. (“Recor”), a wholly owned subsidiary of Otsuka Medical Devices Co., Ltd., announced today that the Paradise™ Ultrasound Renal ...
TOKYO--(BUSINESS WIRE)--Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) announced that the Paradise™ Ultrasound Renal Denervation (uRDN) system has received approval for manufacturing and ...
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
As scar tissue replaces healthy liver tissue, the liver can no longer function properly. Ascites is the accumulation of fluid in the abdominal cavity, causing swelling and discomfort. It’s a common ...
WINREVAIR significantly reduced the risk of clinical worsening events in recently diagnosed PAH patients over 70 percent of whom were on double background therapy HYPERION, third Phase 3 study to ...
Galectin Therapeutics is hosting a virtual key opinion leader (KOL) event to discuss the unmet needs in treating MASH cirrhosis and portal hypertension, positioning the company as a thought leader in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback